BRISTOL MYERS SQUIBB CO Logo

BRISTOL MYERS SQUIBB CO

A global biopharmaceutical company that discovers, develops, and commercializes medicines.

BMY | US

Overview

Corporate Details

ISIN(s):
US1101222073 (+1 more)
LEI:
Country:
United States of America
Address:
ROUTE 206 AND PROVINCE LINE ROAD, 8543 PRINCETON

Description

Bristol Myers Squibb is a global biopharmaceutical company engaged in the discovery, development, licensing, manufacturing, and commercialization of innovative medicines. The company focuses on addressing serious diseases with significant unmet medical needs, with core therapeutic areas in oncology, immunology, and cardiovascular disease. Its operations encompass the entire product lifecycle, from scientific research and clinical trials to the global distribution and sale of its biopharmaceutical products. The company's mission is to help patients prevail over serious diseases through scientific innovation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-18 17:41
CURRENT REPORT
English 856.2 KB
2025-11-12 11:06
NYSE CERTIFICATION
English 252.6 KB
2025-11-10 17:45
8-A12B
English 12.2 KB
2025-11-10 17:06
FORM 8-K
English 1.6 MB
2025-11-07 17:11
424B5
English 673.2 KB
2025-11-05 22:50
FWP
English 17.4 KB
2025-11-04 23:19
FORM 4
English 7.4 KB
2025-11-04 23:18
FORM 4
English 8.2 KB
2025-11-04 23:15
FORM 4
English 7.5 KB
2025-11-04 23:13
FORM 4
English 7.7 KB
2025-11-03 12:09
CURRENT REPORT
English 738.5 KB
2025-11-03 12:02
424B2
English 609.2 KB
2025-10-31 17:11
POSASR
English 1.3 MB
2025-10-31 14:48 English 8.6 KB
2025-10-30 17:04
10-Q
English 2.3 MB

Automate Your Workflow. Get a real-time feed of all BRISTOL MYERS SQUIBB CO filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BRISTOL MYERS SQUIBB CO

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BRISTOL MYERS SQUIBB CO via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.